Intervention Review

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

  1. Kathrin Bauer*,
  2. Nicole Skoetz,
  3. Ina Monsef,
  4. Andreas Engert,
  5. Corinne Brillant

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 10 AUG 2011

Assessed as up-to-date: 29 AUG 2010

DOI: 10.1002/14651858.CD007941.pub2


How to Cite

Bauer K, Skoetz N, Monsef I, Engert A, Brillant C. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD007941. DOI: 10.1002/14651858.CD007941.pub2.

Author Information

  1. University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

*Kathrin Bauer, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50924, Germany. kathrin.bauer@uk-koeln.de.

Publication History

  1. Publication Status: New
  2. Published Online: 10 AUG 2011

SEARCH